BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12394187)

  • 1. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes.
    Ragnarsson-Olding BK; Karsberg S; Platz A; Ringborg UK
    Melanoma Res; 2002 Oct; 12(5):453-63. PubMed ID: 12394187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.
    Jiveskog S; Ragnarsson-Olding B; Platz A; Ringborg U
    J Invest Dermatol; 1998 Nov; 111(5):757-61. PubMed ID: 9804334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin.
    Ragnarsson-Olding B; Platz A; Olding L; Ringborg U
    Melanoma Res; 2004 Oct; 14(5):395-401. PubMed ID: 15457096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
    Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
    Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.
    Cohen Y; Rosenbaum E; Begum S; Goldenberg D; Esche C; Lavie O; Sidransky D; Westra WH
    Clin Cancer Res; 2004 May; 10(10):3444-7. PubMed ID: 15161700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of BRAF mutations in UV-protected mucosal melanomas.
    Edwards RH; Ward MR; Wu H; Medina CA; Brose MS; Volpe P; Nussen-Lee S; Haupt HM; Martin AM; Herlyn M; Lessin SR; Weber BL
    J Med Genet; 2004 Apr; 41(4):270-2. PubMed ID: 15060100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites.
    Essner R; Kuo CT; Wang H; Wen DR; Turner RR; Nguyen T; Hoon DS
    Cancer; 1998 Jan; 82(2):309-16. PubMed ID: 9445187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of ras gene mutations in UV-induced malignant melanomas correlates with a dermal origin of melanocytes in Monodelphis domestica.
    Chan J; Robinson ES; Yeh IT; McCarrey JR
    Cancer Lett; 2002 Oct; 184(1):73-80. PubMed ID: 12104050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.
    Eskandarpour M; Hashemi J; Kanter L; Ringborg U; Platz A; Hansson J
    J Natl Cancer Inst; 2003 Jun; 95(11):790-8. PubMed ID: 12783933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
    Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of p53 gene mutations in cutaneous melanoma.
    Lübbe J; Reichel M; Burg G; Kleihues P
    J Invest Dermatol; 1994 May; 102(5):819-21. PubMed ID: 8176269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
    Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
    Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites.
    Deichmann M; Krahl D; Thome M; Wüst K; Hassanzadeh J; Helmke B
    Int J Oncol; 2006 Jul; 29(1):139-45. PubMed ID: 16773193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
    Kumar R; Angelini S; Hemminki K
    Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene mutation and expression in naevi and melanomas.
    Sparrow LE; Soong R; Dawkins HJ; Iacopetta BJ; Heenan PJ
    Melanoma Res; 1995 Apr; 5(2):93-100. PubMed ID: 7620345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare.
    Kumar R; Smeds J; Berggren P; Straume O; Rozell BL; Akslen LA; Hemminki K
    Int J Cancer; 2001 Nov; 95(6):388-93. PubMed ID: 11668523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet radiation drives mutations in a subset of mucosal melanomas.
    Mundra PA; Dhomen N; Rodrigues M; Mikkelsen LH; Cassoux N; Brooks K; Valpione S; Reis-Filho JS; Heegaard S; Stern MH; Roman-Roman S; Marais R
    Nat Commun; 2021 Jan; 12(1):259. PubMed ID: 33431815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
    Tong Y; Smith MA; Tucker SB
    J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.
    Carr J; Mackie RM
    Br J Dermatol; 1994 Jul; 131(1):72-7. PubMed ID: 8043423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there more than one road to melanoma?
    Rivers JK
    Lancet; 2004 Feb; 363(9410):728-30. PubMed ID: 15005091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.